MedTrace Logo

Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment

NCT06028087 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 736

Last updated 2025-03-14

No results posted yet for this study

Summary

The goal of this observational study is to learn about antithrombotic regimens in Multiple myeloma patients. The main question it aims to answer is the efficacy of different types of thromboprophylaxis (antiplatelet agents, heparins, oral anticoagulants) in preventing venous thromboembolism (VTE).

Conditions

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Valerio De Stefano · Università Cattolica, Fondazione Policlinico A. Gemelli IRCCS, Roma

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-10
Primary Completion
2030-03-31
Completion
2030-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06028087 on ClinicalTrials.gov